Antibodies to Interferon beta in Patients with Multiple Sclerosis Receiving CinnoVex, Rebif, and Betaferon

Treatment with interferon beta (IFN-β) induces the production of binding antibodies (BAbs) and neutralizing antibodies (NAbs) in patients with multiple sclerosis (MS). NAbs against IFN-β are associated with a loss of IFN-β bioactivity and decreased clinical efficacy of the drug. The objective of thi...

Descripción completa

Detalles Bibliográficos
Autores principales: Zare, Nasrin, Zarkesh-Esfahani, Sayyed Hamid, Gharagozloo, Marjan, Shaygannejad, Vahid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Academy of Medical Sciences 2013
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3857378/
https://www.ncbi.nlm.nih.gov/pubmed/24339712
http://dx.doi.org/10.3346/jkms.2013.28.12.1801

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3857378/
https://www.ncbi.nlm.nih.gov/pubmed/24339712
http://dx.doi.org/10.3346/jkms.2013.28.12.1801

Ejemplares similares